Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib

被引：0
|
作者：
Shukaib Arslan
Haris Ali
Mathew Mei
Guido Marcucci
Stephan Forman
Ryotaro Nakamura
Anthony Stein
Monzr M. Al Malki
机构：
[1] City of Hope National Medical Center,Department of Hematology and Hematopoietic Cell Transplantation
来源：
Bone Marrow Transplantation | 2022年 / 57卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：830 / 833
页数：3
相关论文
共 50 条
  • [1] Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib
    Arslan, Shukaib
    Ali, Haris
    Mei, Mathew
    Marcucci, Guido
    Forman, Stephan
    Nakamura, Ryotaro
    Stein, Anthony
    Al Malki, Monzr M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (05) : 830 - 833
  • [2] Ibrutinib for Pure Red Cell Aplasia after Allogeneic Hematopoietic Stem Cell Transplant with Major ABO Incompatibility
    Arslan, Shukaib
    Stein, Anthony S.
    Forman, Stephen J.
    Nakamura, Ryotaro
    Al Malki, Monzr M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S362 - S363
  • [3] Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant
    Sackett, Katie
    Cohn, Claudia S.
    Fahey-Ahrndt, Kayla
    Smith, Angela R.
    Johnson, Andrew D.
    JOURNAL OF CLINICAL APHERESIS, 2018, 33 (01) : 108 - 112
  • [4] Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment
    Henig, Israel
    Yehudai-Ofir, Dana
    Zohar, Yaniv
    Zuckerman, Tsila
    ACTA HAEMATOLOGICA, 2021, 144 (06) : 683 - 687
  • [5] Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib
    Poon, L-M
    Koh, L. P.
    BONE MARROW TRANSPLANTATION, 2012, 47 (06) : 870 - 871
  • [6] Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
    Asawapanumas, Thiti
    Chanswangphuwana, Chantiya
    Watanaboonyongcharoen, Phandee
    Rojnuckarin, Ponlapat
    Bunworasate, Udomsak
    LEUKEMIA RESEARCH REPORTS, 2022, 17
  • [7] Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib
    L-M Poon
    L P Koh
    Bone Marrow Transplantation, 2012, 47 : 870 - 871
  • [8] Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
    Asawapanumas, Thiti
    Chanswangphuwana, Chantiya
    Watanaboonyongcharoen, Phandee
    Rojnuckarin, Ponlapat
    Bunworasate, Udomsak
    LEUKEMIA RESEARCH REPORTS, 2022, 17
  • [9] Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab
    Cao, Junjie
    Lu, Shaoyan
    Luo, Danjie
    Pei, Renzhi
    Lu, Ying
    Chen, Dong
    Du, Xiaohong
    Li, Shuangyue
    TRANSFUSION, 2024, 64 (03) : 510 - 516
  • [10] PURE RED CELL APLASIA IN MAJOR ABO MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ASSOCIATED WITH SEVERE PANCYTOPENIA
    Aung, F.
    Lichtiger, B.
    Gabriela, R.
    Alousi, A.
    Ahmed, S.
    Andersson, B.
    Bashir, Q.
    Stefan, C.
    Hosing, C.
    Jones, R.
    Kebriaei, P.
    Khouri, I.
    Nieto, Y.
    Betul, O.
    Parmar, S.
    Qazilbash, M.
    Shah, N.
    Shpall, E.
    Champlin, R.
    Popat, U.
    HAEMATOLOGICA, 2015, 100 : 279 - 279
12345